We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.19B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+23.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$352M
Cap. Flow
+$253M
Cap. Flow %
10.89%
Top 10 Hldgs %
74.25%
Holding
37
New
4
Increased
8
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
FLR icon
Fluor
FLR
+$152M
2
GPK icon
Graphic Packaging
GPK
+$84.6M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$51.8M
4
CI icon
Cigna
CI
+$30.2M
5
WFRD icon
Weatherford International
WFRD
+$23.4M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$52.3M
2
DLTR icon
Dollar Tree
DLTR
+$32.8M
3
PTON icon
Peloton Interactive
PTON
+$31.3M
4
KD icon
Kyndryl
KD
+$29.8M
5
ROIV icon
Roivant Sciences
ROIV
+$9.65M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.02%
2 Energy 13.88%
3 Industrials 12.81%
4 Healthcare 10.21%
5 Technology 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDX icon
26
VanEck Gold Miners ETF
GDX
$27.5B
$3.98M 0.17%
76,460
OIH icon
27
VanEck Oil Services ETF
OIH
$1.97B
$3.67M 0.16%
15,940
+3,580
+29% +$804K
SHC icon
28
Sotera Health
SHC
$5.45B
$2.6M 0.11%
+233,690
New +$2.74M
GPRO icon
29
GoPro
GPRO
$107M
$2.14M 0.09%
2,823,100
PTON icon
30
Peloton Interactive
PTON
$2.46B
$1.25M 0.05%
179,470
-4,823,938
-96% -$31.3M
GANX icon
31
Gain Therapeutics
GANX
$87.9M
$1.02M 0.04%
566,130
NUVB icon
32
Nuvation Bio
NUVB
$2.24B
$68.2K ﹤0.01%
34,995
NUVB.WS
33
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$27K ﹤0.01%
100,000
KPLTW
34
DELISTED
Katapult Holdings Warrant
KPLTW
$2.08K ﹤0.01%
262,227
ALIT icon
35
Alight
ALIT
$364M
-50,000
Closed -$5.93M
DLTR icon
36
Dollar Tree
DLTR
$24.6B
-436,360
Closed -$32.8M
VTRS icon
37
Viatris
VTRS
$18.7B
-6,000,830
Closed -$52.3M

Similar funds

DME Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, DME Capital Management held 37 positions worth $2.33B, up 18% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DME Capital Management deployed $253M of net new capital in Q2 2025, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Fluor: 3,819,580 shares worth $196M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, down from 40% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Peloton Interactive, an estimated $31.3M trimmed.

  • DME Capital Management's largest Q2 2025 buy was Fluor: 3,819,580 shares worth $196M.
  • DME Capital Management added most to Graphic Packaging in Q2 2025, an estimated $84.6M increase.
  • DME Capital Management's biggest Q2 2025 reduction was Peloton Interactive, cutting an estimated $31.3M.
  • DME Capital Management fully exited Viatris in Q2 2025, selling an estimated $52.3M.
  • DME Capital Management's ten largest holdings make up 74% of its $2.33B portfolio in Q2 2025.
  • DME Capital Management opened 4 new positions and closed 3 in Q2 2025.
  • DME Capital Management's portfolio value rose 18% quarter-over-quarter to $2.33B.

Based on DME Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.